Venus Medtech concludes patient enrolment for Venus-PowerX trial
Venus Medtech has concluded enrolment of patients in the confirmatory clinical trial for the Venus-PowerX transcatheter aortic valve system in…
24 Jul 2026
Dosing commences in Bio-Thera’s Phase I solid tumour study of BAT8013
Bio-Thera Solutions has initiated dosing in a Phase I clinical trial of BAT8013, an antibody drug conjugate (ADC) designed to target cluster of differentiation 25 (CD25), in patients with advanced…
24 Jul 2026
FDA grants fast track designation for Lundbeck’s Lu AH69593
Lundbeck has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational treatment, Lu AH69593, to treat narcolepsy. Lu AH69593 is an oral, small-molecule agonist…
23 Jul 2026
Affinia Therapeutics receives FDA orphan drug designation for AFTX-201
Affinia Therapeutics has received the US Food and Drug Administration (FDA) orphan drug designation for AFTX-201, a treatment in development for BAG3-associated dilated cardiomyopathy (DCM). The gene therapy is under…
23 Jul 2026
bioAffinity and Pictor partner on diagnostics for asthma and COPD
bioAffinity Technologies has collaborated with Pictor to develop and commercialise new diagnostic tests for asthma and chronic obstructive pulmonary disease (COPD). The partnership aims to provide a broader assessment of…
23 Jul 2026
Ribo reports vortosiran Phase IIa trial results for coronary artery disease
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals, collectively known as Ribo, has reported initial results from its Phase IIa clinical trial of vortosiran (RBD4059) in patients with chronic coronary…
22 Jul 2026
Philips secures FDA clearance for SpO₂ clip sensor
Philips has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its next-generation reusable SpO₂ clip sensor. The product is designed to provide consistent oxygen saturation measurements…